• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小剂量泼尼松龙与肝素钠预防输注性血栓性静脉炎的疗效:一项双盲试验

On the efficacy of low dose prednisolone and heparin sodium in the prevention of infusion thrombophlebitis. A double-blind trial.

作者信息

De Cock C, Vermeij P, Stijnen T

出版信息

Pharm Weekbl Sci. 1984 Apr 27;6(2):88-90. doi: 10.1007/BF01953960.

DOI:10.1007/BF01953960
PMID:6728639
Abstract

A prospective, double-blind investigation into the effectiveness of the addition to infusion fluids of an injectable containing 0.3 mg prednisolone and 10 units heparin per ml in a phosphate buffer pH = 7.5 versus the phosphate buffer alone is described. 196 Patients were allocated alternately to each group. On a total number of 593 cannulation days, 16 cases of thrombophlebitis were diagnosed. Statistical evaluation revealed a significant difference between the two groups (p less than 0.01) in favour of prednisolone + heparin sodium.

摘要

本文描述了一项前瞻性、双盲研究,旨在对比在pH = 7.5的磷酸盐缓冲液中,每毫升添加0.3毫克泼尼松龙和10单位肝素的注射剂与单独使用磷酸盐缓冲液添加到输液中的效果。196名患者被交替分配到每组。在总共593个置管日中,诊断出16例血栓性静脉炎。统计评估显示两组之间存在显著差异(p小于0.01),支持泼尼松龙 + 肝素钠组。

相似文献

1
On the efficacy of low dose prednisolone and heparin sodium in the prevention of infusion thrombophlebitis. A double-blind trial.小剂量泼尼松龙与肝素钠预防输注性血栓性静脉炎的疗效:一项双盲试验
Pharm Weekbl Sci. 1984 Apr 27;6(2):88-90. doi: 10.1007/BF01953960.
2
Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.全髋关节置换术后深静脉血栓形成和肺栓塞的预防。低分子量肝素与普通肝素的比较。
J Bone Joint Surg Am. 1991 Apr;73(4):484-93.
3
Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.低分子量肝素预防全髋关节置换患者深静脉血栓形成。一项随机试验。德国髋关节置换试验(GHAT)组。
Arch Orthop Trauma Surg. 1992;111(2):110-20. doi: 10.1007/BF00443477.
4
Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis. A multicenter trial. The Multicenter Trial Committee.双氢麦角胺-肝素预防术后深静脉血栓形成。一项多中心试验。多中心试验委员会。
JAMA. 1984 Jun 8;251(22):2960-6. doi: 10.1001/jama.1984.03340460038022.
5
A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture.
J Trauma. 1989 Jun;29(6):873-5. doi: 10.1097/00005373-198906000-00028.
6
Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.使用重组水蛭素预防血栓栓塞。一项双盲、多中心试验的结果,该试验比较了地西卢定(Revasc)与普通肝素在全髋关节置换患者中的疗效。
J Bone Joint Surg Am. 1997 Mar;79(3):326-33. doi: 10.2106/00004623-199703000-00002.
7
Effects of heparin versus saline solution on intermittent infusion device irrigation.肝素与盐溶液对间歇性输液装置冲洗的影响。
Heart Lung. 1990 Nov;19(6):608-12.
8
Postoperative deep vein thrombosis of the lower limb and prophylactic value of heparin evaluated by phlebography.通过静脉造影术评估下肢术后深静脉血栓形成及肝素的预防价值。
Acta Radiol Diagn (Stockh). 1979;20(3):507-12. doi: 10.1177/028418517902000312.
9
A comparison between subcutaneous low-dose sodium and calcium heparin. Prophylaxis of postoperative deep vein thrombosis and side effects of treatment.皮下注射低剂量钠肝素与钙肝素的比较。术后深静脉血栓形成的预防及治疗副作用。
Acta Chir Scand. 1978;144(6):339-42.
10
Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group.依诺肝素与普通肝素预防择期癌症手术中深静脉血栓形成的疗效和安全性:一项采用静脉造影评估的双盲随机多中心试验。依诺肝素预防癌症手术患者深静脉血栓形成研究组
Br J Surg. 1997 Aug;84(8):1099-103.

引用本文的文献

1
Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbits.皮质类固醇对兔静脉输注抗肿瘤药物所致静脉炎的影响。
Int J Med Sci. 2009 Aug 6;6(5):218-23. doi: 10.7150/ijms.6.218.
2
Survival of intravenous chemotherapy infusion sites.静脉化疗输注部位的存活情况。
Br J Cancer. 1990 Oct;62(4):660-2. doi: 10.1038/bjc.1990.351.
3
Potential for extending survival of peripheral intravenous infusions.延长外周静脉输液存活时间的潜力。

本文引用的文献

1
Morbid and mortal complications associated with prolonged central venous cannulation. Awareness, recognition, and prevention.与长期中心静脉置管相关的发病和死亡并发症。认识、识别与预防。
Am J Surg. 1971 May;121(5):600-5. doi: 10.1016/0002-9610(71)90149-8.
2
Fibrin sleeve formation on indwelling subclavian central venous catheters.锁骨下留置中心静脉导管上纤维蛋白套的形成
Arch Surg. 1971 Apr;102(4):353-8. doi: 10.1001/archsurg.1971.01350040115023.
3
Infection control in intravenous therapy.静脉治疗中的感染控制
BMJ. 1992 Mar 7;304(6827):619-24. doi: 10.1136/bmj.304.6827.619.
Ann Intern Med. 1973 Dec;79(6):867-87. doi: 10.7326/0003-4819-79-6-867.
4
Infusion thrombophlebitis and its prevention.
Am Heart J. 1967 May;73(5):717-8. doi: 10.1016/0002-8703(67)90185-8.
5
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.需要对每位患者进行长期观察的随机临床试验的设计与分析。II. 分析与示例。
Br J Cancer. 1977 Jan;35(1):1-39. doi: 10.1038/bjc.1977.1.